As such, the concept of an IDH-mutant glioblastoma became obsolete, as the prognostic implications and underlying molecular alterations of IDH-mutant and IDH-wildtype gliomas were shown to be distinct [9,10,11]. This evidence concerns the gene IDH2 and glioblastoma.